News & Updates
Filter by Specialty:

Minimally invasive surgery feasible for nonendometroid endometrial cancers
Minimally invasive surgery for nonendometrioid endometrial cancer performs comparably as open surgery, yielding similar survival outcomes, a recent study has found.
Minimally invasive surgery feasible for nonendometroid endometrial cancers
26 Oct 2021
Dose-capping chemoradiotherapy tied to higher recurrence in rectal cancer
The risk of disease recurrence is increased among rectal cancer patients treated with dose-capped chemoradiotherapy (CRT), reveals a study. In addition, excessive toxicity has occurred among those dosed by actual body surface area (BSA) compared to patients in the dose-capped group.
Dose-capping chemoradiotherapy tied to higher recurrence in rectal cancer
24 Oct 2021
Novel score predicts survival, radiological response in HCC
The novel CRAFITY score—which takes into account C-reactive protein (CRP), alpha-foetoprotein (AFP), and immunotherapy—can be used to reliably assess survival and radiological response in hepatocellular carcinoma (HCC), a recent study has found. Future validation is needed before CRAFITY can be deployed to the clinics.
Novel score predicts survival, radiological response in HCC
24 Oct 2021
Negative upper endoscopy findings in GERD signal lower upper gastrointestinal cancer risk
Negative upper endoscopy findings in patients with gastroesophageal reflux disease (GERD) indicate lower risk of developing upper gastrointestinal cancer, a new study has found.
Negative upper endoscopy findings in GERD signal lower upper gastrointestinal cancer risk
21 Oct 2021
NLR, PLR improve early detection of second primary cancer after gastric cancer
Combining the neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios with existing diagnostic methods helps improve early detection of second primary cancers (SPC) after initial gastric cancer (GC), a recent study has found.
NLR, PLR improve early detection of second primary cancer after gastric cancer
20 Oct 2021
DOACs on par with LMWH at preventing VTE in cancer patients
Cancer patients receiving either low-molecular-weight heparin (LMWH) or direct oral anticoagulants (DOACs) show comparable frequency of venous thromboembolism (VTE), reports a recent study.